0001104659-20-007119.txt : 20200127
0001104659-20-007119.hdr.sgml : 20200127
20200127160633
ACCESSION NUMBER: 0001104659-20-007119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200123
FILED AS OF DATE: 20200127
DATE AS OF CHANGE: 20200127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kimble Eric Wilson
CENTRAL INDEX KEY: 0001775333
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38670
FILM NUMBER: 20549597
MAIL ADDRESS:
STREET 1: C/O ENTASIS THERAPEUTICS HOLDINGS INC.
STREET 2: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entasis Therapeutics Holdings Inc.
CENTRAL INDEX KEY: 0001724344
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824592913
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 810-0120
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Entasis Therapeutics Ltd
DATE OF NAME CHANGE: 20171204
4
1
a4.xml
4
X0306
4
2020-01-23
0
0001724344
Entasis Therapeutics Holdings Inc.
ETTX
0001775333
Kimble Eric Wilson
C/O ENTASIS THERAPEUTICS HOLDINGS INC.,
35 GATEHOUSE DRIVE
WALTHAM
MA
02451
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
4.94
2020-01-23
4
A
0
50000
0
A
2030-01-22
Common Stock
50000
50000
D
Twenty-five percent (25%) of the shares subject to the option shall vest on January 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Elizabeth M. Keiley as Attorney-in-Fact for Eric Wilson Kimble
2020-01-27